Clinical Trial Update: A Study of Women With an Early Diagnosis of Breast Cancer, Taking Celecoxib Between the Biopsy and Lumpectomy/Mastectomy [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and feasibility of taking celecoxib between biopsy and lumpectomy/mastectomy in women with early breast cancer; the trial ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CELEBREX (Celecoxib)

Snippet

Sponsor: University of Kansas | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED